Andrew R. Robbins
2016
In 2016, Andrew R. Robbins earned a total compensation of $1.2M as Chief Operating Officer at Array BioPharma, a 51% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $236,250 |
|---|---|
| Option Awards | $362,168 |
| Salary | $413,306 |
| Stock Awards | $118,125 |
| Other | $34,829 |
| Total | $1,164,678 |
Robbins received $413.3K in salary, accounting for 35% of the total pay in 2016.
Robbins also received $236.3K in non-equity incentive plan, $362.2K in option awards, $118.1K in stock awards and $34.8K in other compensation.
Rankings
In 2016, Andrew R. Robbins' compensation ranked 7,498th out of 14,075 executives tracked by ExecPay. In other words, Robbins earned more than 46.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,498 out of 14,075 | 47th |
Division Manufacturing | 2,840 out of 5,489 | 48th |
Major group Chemicals And Allied Products | 938 out of 1,895 | 51st |
Industry group Drugs | 725 out of 1,538 | 53rd |
Industry Pharmaceutical Preparations | 579 out of 1,176 | 51st |
Source: SEC filing on September 13, 2017.
Robbins' colleagues
We found five more compensation records of executives who worked with Andrew R. Robbins at Array BioPharma in 2016.